Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 18872 publications
Global Mumps Vaccine Market Research Report 2016 US$ 2,850.00

2016 Global Mumps Vaccine Market Report is a professional and in-depth research report on the world's major regional market conditions of the Mumps Vaccine industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Mumps Vaccine industry; 3.) the North American Mumps Vaccine industry; 4.) the European Mumps Vaccine industry; 5.) market entry and investment feasibility; and ...

Sep, 2016 151 pages
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2016 US$ 3,500.00

... therapeutic landscape for Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) The report reviews Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) targeted therapeutics under development ...

Aug, 2016 43 pages
Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) - Pipeline Review, H2 2016 US$ 3,500.00

... Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) The report reviews Tryptophan 2,3 Dioxygenase (Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11) targeted therapeutics under development ...

Aug, 2016 39 pages
Sage Therapeutics, Inc. - Product Pipeline Review - 2016 US$ 1,500.00

... molecule type The report features Sage Therapeutics, Inc.’s out-licensed and partnered product portfolio ... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Sage Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics ...

Aug, 2016 42 pages
Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline... US$ 3,500.00

... Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) The report reviews Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros ...

Aug, 2016 59 pages
Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016 US$ 3,500.00

... for Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) The report reviews Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein ...

Aug, 2016 51 pages
Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) - Pipeline Review, H2 2016 US$ 3,500.00

... Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit Kv7.3 or KCNQ3) The report reviews Potassium Voltage Gated Channel Subfamily KQT Member 3 (Potassium Channel Subunit Alpha KvLQT3 or Voltage Gated Potassium Channel Subunit ...

Aug, 2016 49 pages
Potassium Voltage Gated Channel Subfamily C Member 1 (Voltage Gated Potassium Channel Subunit Kv3.1 or Voltage Gated Potassium Channel Subunit Kv4 or KCNC1) - Pipeline Review, H2 2016 US$ 3,500.00

... 1 (Voltage Gated Potassium Channel Subunit Kv3.1 or Voltage Gated Potassium Channel Subunit Kv4 or KCNC1) The report reviews Potassium Voltage Gated Channel Subfamily C Member 1 (Voltage Gated Potassium Channel Subunit Kv3.1 or Voltage Gated Potassium Channel Subunit Kv4 or KCNC1) targeted therapeutics under ...

Aug, 2016 32 pages
NanoViricides, Inc. - Product Pipeline Review - 2016 US$ 1,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding NanoViricides, Inc.’s pipeline depth and focus of pipeline therapeutics ...

Aug, 2016 46 pages
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016 US$ 3,500.00

... Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016’, provides in depth analysis on N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) targeted pipeline therapeutics ...

Aug, 2016 45 pages
Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016 US$ 3,500.00

... therapeutic landscape for Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) The report reviews Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) targeted therapeutics under development ...

Aug, 2016 38 pages
Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H2 2016 US$ 3,500.00

... ‘Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H2 2016’, provides in depth analysis on Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 ...

Aug, 2016 46 pages
Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H2 2016 US$ 3,500.00

... Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) The report reviews Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) targeted therapeutics under development ...

Aug, 2016 72 pages
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016 US$ 3,500.00

... Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016’, provides in depth analysis on Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) targeted pipeline therapeutics. The report provides comprehensive information on the Frataxin ...

Aug, 2016 45 pages
Coronaviridae Infections - Pipeline Review, H2 2016 US$ 2,000.00

... Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Coronaviridae Infections - Pipeline Review, H2 2016’, provides an overview of the Coronaviridae Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Coronaviridae Infections ...

Aug, 2016 101 pages
Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016 US$ 3,500.00

... Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016’, provides in depth analysis on Cell Division Protein FtsZ (ftsz) targeted pipeline therapeutics. The report provides comprehensive information on the Cell Division Protein FtsZ (ftsz), targeted therapeutics ...

Aug, 2016 44 pages
Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016 US$ 3,500.00

... Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016’, provides in depth analysis on Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted pipeline therapeutics ...

Aug, 2016 90 pages
Arrowhead Pharmaceuticals, Inc. - Product Pipeline Review - 2016 US$ 1,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Arrowhead Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics ...

Aug, 2016 42 pages
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) - Pipeline Review, H2 2016 US$ 2,000.00

... Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis), complete with analysis by stage of development ...

Aug, 2016 87 pages
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) -... US$ 3,500.00

... Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 (A Disintegrin And Metalloproteinase With Thrombospondin Motifs 11 or Aggrecanase 2 or ADMP2 or ADAMTS5 or EC 3.4.24.) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘A Disintegrin And Metalloproteinase With Thrombospondin Motifs ...

Aug, 2016 31 pages
United States Zolmitriptan Nasal Spray Market Report 2016 US$ 3,800.00

... , means the sales volume of Zolmitriptan Nasal Spray Revenue, means the sales value of Zolmitriptan Nasal Spray This report studies sales (consumption) of Zolmitriptan Nasal Spray in USA market, focuses on the ... , this report focuses on sales, market share and growth rate of Zolmitriptan Nasal Spray in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 119 pages
United States Troponin Tissue-Specific Subtypes Market Report 2016 US$ 3,800.00

... , means the sales volume of Troponin Tissue-Specific Subtypes Revenue, means the sales value of Troponin Tissue-Specific Subtypes This report studies sales (consumption) of Troponin Tissue-Specific Subtypes in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Troponin Tissue-Specific Subtypes in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 123 pages
United States Thrombus Precursor Protein Market Report 2016 US$ 3,800.00

... , means the sales volume of Thrombus Precursor Protein Revenue, means the sales value of Thrombus Precursor Protein This report studies sales (consumption) of Thrombus Precursor Protein in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Thrombus Precursor Protein in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 119 pages
United States Stem-Cell Based Bone Grafts Market Report 2016 US$ 3,800.00

... sales volume of Stem-Cell Based Bone Grafts Revenue, means the sales value of Stem-Cell Based Bone Grafts This report studies sales (consumption) of Stem-Cell Based Bone Grafts in United States market, focuses on the ... , this report focuses on sales, market share and growth rate of Stem-Cell Based Bone Grafts in each application, can be divided into Application 1 Application 2 Application ...

Sep, 2016 118 pages
United States Stadol Nasal Spray Market Report 2016 US$ 3,800.00

... , means the sales volume of Stadol Nasal Spray Revenue, means the sales value of Stadol Nasal Spray This report studies sales (consumption) of Stadol Nasal Spray in USA market, focuses on the ... , this report focuses on sales, market share and growth rate of Stadol Nasal Spray in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 118 pages
United States Solid Tumors Drugs Market Report 2016 US$ 3,800.00

... , means the sales volume of Solid Tumors Drugs Revenue, means the sales value of Solid Tumors Drugs This report studies sales (consumption) of Solid Tumors Drugs in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Solid Tumors Drugs in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 116 pages
United States Prostate Cancer Drugs Market Report 2016 US$ 3,800.00

... , means the sales volume of Prostate Cancer Drugs Revenue, means the sales value of Prostate Cancer Drugs This report studies sales (consumption) of Prostate Cancer Drugs in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Prostate Cancer Drugs in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 115 pages
United States Prostacyclin Market Report 2016 US$ 3,800.00

... , means the sales volume of Prostacyclin Revenue, means the sales value of Prostacyclin This report studies sales (consumption) of Prostacyclin in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Actelion Pharmaceuticals Ltd. United ...

Sep, 2016 124 pages
United States Prostacyclin Analogs Market Report 2016 US$ 3,800.00

... , means the sales volume of Prostacyclin Analogs Revenue, means the sales value of Prostacyclin Analogs This report studies sales (consumption) of Prostacyclin Analogs in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Actelion Pharmaceuticals Ltd. United ...

Sep, 2016 123 pages
United States Polypeptide Drug Market Report 2016 US$ 3,800.00

... , means the sales volume of Polypeptide Drug Revenue, means the sales value of Polypeptide Drug This report studies sales (consumption) of Polypeptide Drug in United States market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 123 pages
United States Polymer Based Bone Grafts Market Report 2016 US$ 3,800.00

... sales volume of Polymer Based Bone Grafts Revenue, means the sales value of Polymer Based Bone Grafts This report studies sales (consumption) of Polymer Based Bone Grafts in United States market, focuses on the ... , this report focuses on sales, market share and growth rate of Polymer Based Bone Grafts in each application, can be divided into Application 1 Application 2 Application ...

Sep, 2016 115 pages
United States Plasminogen Activator Inhibitor Market Report 2016 US$ 3,800.00

... , means the sales volume of Plasminogen Activator Inhibitor Revenue, means the sales value of Plasminogen Activator Inhibitor This report studies sales (consumption) of Plasminogen Activator Inhibitor in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Plasminogen Activator Inhibitor in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 122 pages
United States Phosphodiesterase V Inhibitors Market Report 2016 US$ 3,800.00

... volume of Phosphodiesterase V Inhibitors Revenue, means the sales value of Phosphodiesterase V Inhibitors This report studies sales (consumption) of Phosphodiesterase V Inhibitors in USA market ... player, covering Actelion Pharmaceuticals Ltd. United Therapeutics Corporation Gilead sciences Bayer AG SteadyMed ...

Sep, 2016 123 pages
United States Phosphodiesterase Inhibitor Market Report 2016 US$ 3,800.00

... , means the sales volume of Phosphodiesterase Inhibitor Revenue, means the sales value of Phosphodiesterase Inhibitor This report studies sales (consumption) of Phosphodiesterase Inhibitor in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering Actelion Pharmaceuticals Ltd. United ...

Sep, 2016 122 pages
United States Patanase Market Report 2016 US$ 3,800.00

... , means the sales volume of Patanase Revenue, means the sales value of Patanase This report studies sales (consumption) of Patanase in USA market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 118 pages
United States NT-proBNP (N-terminal proBNP) Market Report 2016 US$ 3,800.00

... , means the sales volume of NT-proBNP (N-terminal proBNP) Revenue, means the sales value of NT-proBNP (N-terminal proBNP) This report studies sales (consumption) of NT-proBNP (N-terminal proBNP) in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of NT-proBNP (N-terminal proBNP) in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 123 pages
United States Natriuretic Peptides Market Report 2016 US$ 3,800.00

... , means the sales volume of Natriuretic Peptides Revenue, means the sales value of Natriuretic Peptides This report studies sales (consumption) of Natriuretic Peptides in United States market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 119 pages
United States Nasal Spray Market Report 2016 US$ 3,800.00

... , price, market share and growth rate of each type, can be divided into Astelin Nasal Spray Otrivin Nasal Spray Livostin Nasal Spray Stadol Nasal Spray Zolmitriptan Nasal Spray Corticosteroid Nasal Spray Antihistamine Nasal Spray Split by applications, this report focuses on sales, market share and growth rate of Nasal Spray in each ...

Sep, 2016 124 pages
United States Myoglobin Market Report 2016 US$ 3,800.00

... , means the sales volume of Myoglobin Revenue, means the sales value of Myoglobin This report studies sales (consumption) of Myoglobin in United States market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 119 pages
United States Migranal Market Report 2016 US$ 3,800.00

... , means the sales volume of Migranal Revenue, means the sales value of Migranal This report studies sales (consumption) of Migranal in USA market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 123 pages
United States Miacalcin Nasal Spray Market Report 2016 US$ 3,800.00

... , means the sales volume of Miacalcin Nasal Spray Revenue, means the sales value of Miacalcin Nasal Spray This report studies sales (consumption) of Miacalcin Nasal Spray in USA market, focuses on the ... , this report focuses on sales, market share and growth rate of Miacalcin Nasal Spray in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 121 pages
United States Livostin Nasal Spray Market Report 2016 US$ 3,800.00

... , means the sales volume of Livostin Nasal Spray Revenue, means the sales value of Livostin Nasal Spray This report studies sales (consumption) of Livostin Nasal Spray in USA market, focuses on the ... , this report focuses on sales, market share and growth rate of Livostin Nasal Spray in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 120 pages
United States Kidney Cancer Drug Market Report 2016 US$ 3,800.00

... , means the sales volume of Kidney Cancer Drug Revenue, means the sales value of Kidney Cancer Drug This report studies sales (consumption) of Kidney Cancer Drug in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Kidney Cancer Drug in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 115 pages
United States Imitrex Market Report 2016 US$ 3,800.00

... , means the sales volume of Imitrex Revenue, means the sales value of Imitrex This report studies sales (consumption) of Imitrex in USA market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 122 pages
United States Hydroxyapatite Market Report 2016 US$ 3,800.00

... , means the sales volume of Hydroxyapatite Revenue, means the sales value of Hydroxyapatite This report studies sales (consumption) of Hydroxyapatite in United States market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 120 pages
United States Homocysteine Market Report 2016 US$ 3,800.00

... , means the sales volume of Homocysteine Revenue, means the sales value of Homocysteine This report studies sales (consumption) of Homocysteine in United States market, focuses on the top players, with sales, price, revenue and market share for ...

Sep, 2016 119 pages
United States Gynecological Cancers Drug Market Report 2016 US$ 3,800.00

... , means the sales volume of Gynecological Cancers Drug Revenue, means the sales value of Gynecological Cancers Drug This report studies sales (consumption) of Gynecological Cancers Drug in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Gynecological Cancers Drug in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 120 pages
United States Gastric Cancer Drugs Market Report 2016 US$ 3,800.00

... , means the sales volume of Gastric Cancer Drugs Revenue, means the sales value of Gastric Cancer Drugs This report studies sales (consumption) of Gastric Cancer Drugs in United States market, focuses on the top ... , this report focuses on sales, market share and growth rate of Gastric Cancer Drugs in each application, can be divided into Application 1 Application 2 Application 3

Sep, 2016 116 pages
United States Endothelin Receptor Antagonist Market Report 2016 US$ 3,800.00

... volume of Endothelin Receptor Antagonist Revenue, means the sales value of Endothelin Receptor Antagonist This report studies sales (consumption) of Endothelin Receptor Antagonist in USA market ... player, covering Actelion Pharmaceuticals Ltd. United Therapeutics Corporation Gilead sciences Bayer AG SteadyMed ...

Sep, 2016 124 pages
United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021 US$ 3,800.00

... of Drugs for Respiratory Syncytial Virus (RSV) Revenue, means the sales value of Drugs for Respiratory Syncytial Virus (RSV) This report studies sales (consumption) of Drugs for Respiratory ...

Sep, 2016 100 pages
1 2 3 4 5 >
Skip to top